Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with Bev-Based Therapy: Overall Survival Subgroup Findings from ML18147
暂无分享,去创建一个
R. Greil | S. Kubicka | C. Borg | D. Arnold | E. Cutsem | J. Bennouna | I. Reyes-Rivera | B. Bendahmane | R. Moos | J. V. D. Prado | D. Arnold | J. M. V. D. Prado